NEW YORK (GenomeWeb) – OncoDNA today announced a distribution deal with Malaysian oncology firm Genesis Genome to bring affordable theranostic analysis to that country. 

Under the terms of the deal, Genesis Genome has selected OncoDNA as its exclusive supplier of clinical grade molecular theranostics and will make available to Malaysian physicians OncoDNA's OncoDeep DX and OncoDeep Clinical cancer panels combined with its Package Plus, enabling clinically relevant interpretations of patients' tumors using the OncoShare web platform. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.